Safety of Vortioxetine in Patients With Depression: A Post‐Marketing Surveillance Study of Intracranial Hemorrhage in a Japanese Health Insurance Claims Database

Authors

Institutions

Publication Details

Journal
Neuropsychopharmacology Reports
Published
2025-12-25
DOI
https://doi.org/10.1002/npr2.70077
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety of Vortioxetine in Patients With Depression: A Post‐Marketing Surveillance Study of Intracranial Hemorrhage in a Japanese Health Insurance Claims Database

Tatsuya Hoshino, Rie OTAKE, Takeshi Inoue
Neuropsychopharmacology Reports
Treatment of Major Depression
article

Safety of Vortioxetine in Patients With Depression: A Post‐Marketing Surveillance Study of Intracranial Hemorrhage in a Japanese Health Insurance Claims Database

Tatsuya Hoshino, Rie OTAKE, Takeshi Inoue
article en

Abstract

No abstract available for this paper.
Neuropsychopharmacology ReportsVol. 46(1)
Tokyo Medical University (JP), Hanazono Hospital (JP), Takeda (Japan) (JP)
Takeda Pharmaceuticals U.S.A., H. Lundbeck A/S
Openalex Percentile: Top 30%
Treatment of Major Depression
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.